2019 APSIC指南:手术部位感染的预防

2019-11-12 亚太感染控制学会 Antimicrob Resist Infect Control. 2019 Nov 12;8:17

2019年11月,亚太感染控制学会(APSIC)发布了手术部位感染预防指南,本文主要针对手术部位感染的预防提出指导建议,目的是以简明的格式突出实践建议,旨在帮助亚太地区医疗机构在术前,围术期以及术后实践中达到更高的标准。

中文标题:

2019 APSIC指南:手术部位感染的预防

英文标题:

APSIC guidelines for the prevention of surgical site infections.

发布机构:

亚太感染控制学会

发布日期:

2019-11-12

简要介绍:

2019年11月,亚太感染控制学会(APSIC)发布了手术部位感染预防指南,本文主要针对手术部位感染的预防提出指导建议,目的是以简明的格式突出实践建议,旨在帮助亚太地区医疗机构在术前,围术期以及术后实践中达到更高的标准。

 

拓展指南:感染相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 APSIC指南:手术部位感染的预防)] GetToolGuiderByIdResponse(projectId=1, id=f11331c00183a502, title=2019 APSIC指南:手术部位感染的预防, enTitle=APSIC guidelines for the prevention of surgical site infections., guiderFrom=Antimicrob Resist Infect Control. 2019 Nov 12;8:17, authorId=null, author=, summary=2019年11月,亚太感染控制学会(APSIC)发布了手术部位感染预防指南,本文主要针对手术部位感染的预防提出指导建议,目的是以简明的格式突出实践建议,旨在帮助亚太地区医疗机构在术前,围术期以及术后实践中达到更高的标准。 , cover=, journalId=null, articlesId=null, associationId=1600, associationName=亚太感染控制学会, associationIntro=, copyright=0, guiderPublishedTime=Tue Nov 12 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年11月,亚太感染控制学会(APSIC)发布了手术部位感染预防指南,本文主要针对手术部位感染的预防提出指导建议,目的是以简明的格式突出实践建议,旨在帮助亚太地区医疗机构在术前,围术期以及术后实践中达到更高的标准。 </P> <P> </P>拓展指南:<strong>与<font color=red>感染</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=aab1f1c001829aa7" title="2019 ISCVID指南:心脏手术体外循环后播散性奇美拉分枝杆菌感染的诊断,治疗和预防" target=_blank>2019 ISCVID指南:心脏手术体外循环后播散性奇美拉分枝杆菌感染的诊断,治疗和预防</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=3343a1c00182e6b0" title="免疫检查点抑制剂相关感染诊治建议" target=_blank>免疫检查点抑制剂相关感染诊治建议</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=772931c00182e244" title="2019 EHRA国际共识:心脏植入性电子设备感染的预防,诊断和治疗" target=_blank>2019 EHRA国际共识:心脏植入性电子设备感染的预防,诊断和治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=3856d1c00182a50e" title="2019 国际专家共识建议:骨折相关感染一般治疗原则" target=_blank>2019 国际专家共识建议:骨折相关感染一般治疗原则</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=861781c00181e229" title="单纯性和复杂性皮肤及软组织感染抗菌药物临床试验指导原则" target=_blank>单纯性和复杂性皮肤及软组织感染抗菌药物临床试验指导原则</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E6%84%9F%E6%9F%93" target=_blank>有关感染更多指南</a></ul>, tagList=[TagDto(tagId=15421, tagName=手术部位感染)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5836, appHits=360, showAppHits=0, pcHits=3187, showPcHits=3613, likes=67, shares=18, comments=6, approvalStatus=1, publishedTime=Sat Nov 30 13:05:03 CST 2019, publishedTimeString=2019-11-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Nov 30 13:05:03 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:26:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 APSIC指南:手术部位感染的预防)])
2019 APSIC指南:手术部位感染的预防
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1007270, encodeId=9eef100e270e4, content=赞 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIwY1mhUqD8P7iaes3oich3QTsdjk48gMrTIWJOIpDZObLeWWyEjhpBhxDsObwqWLGpMtPnMNxeQrbQ/132, createdBy=40802444180, createdName=云霄暖暖, createdTime=Thu Aug 12 13:54:23 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954489, encodeId=44ee954489c0, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:08:28 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905766, encodeId=62a6905e66f9, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/8c4455ab759843818e1f3ed7cde78e76/6d4732742c8a41a4950d5048ba13560e.jpg, createdBy=38792245245, createdName=Terry tao, createdTime=Mon Dec 07 18:08:18 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884790, encodeId=883e884e9037, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/3a02391511574e11a9aa4cf69c274058/49d417ece10545679c44d78fdbb7a881.jpg, createdBy=9b335137041, createdName=索和, createdTime=Sat Sep 12 18:20:12 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814741, encodeId=4f8d814e4173, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/09cdac1bb7b7426a8dd112bd3fd2ad8e/541a6884f1d446a584b766afce6b510b.jpg, createdBy=88875409033, createdName=ms5000001342669861, createdTime=Fri Aug 28 15:37:53 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2021-08-12 云霄暖暖

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1007270, encodeId=9eef100e270e4, content=赞 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIwY1mhUqD8P7iaes3oich3QTsdjk48gMrTIWJOIpDZObLeWWyEjhpBhxDsObwqWLGpMtPnMNxeQrbQ/132, createdBy=40802444180, createdName=云霄暖暖, createdTime=Thu Aug 12 13:54:23 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954489, encodeId=44ee954489c0, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:08:28 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905766, encodeId=62a6905e66f9, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/8c4455ab759843818e1f3ed7cde78e76/6d4732742c8a41a4950d5048ba13560e.jpg, createdBy=38792245245, createdName=Terry tao, createdTime=Mon Dec 07 18:08:18 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884790, encodeId=883e884e9037, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/3a02391511574e11a9aa4cf69c274058/49d417ece10545679c44d78fdbb7a881.jpg, createdBy=9b335137041, createdName=索和, createdTime=Sat Sep 12 18:20:12 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814741, encodeId=4f8d814e4173, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/09cdac1bb7b7426a8dd112bd3fd2ad8e/541a6884f1d446a584b766afce6b510b.jpg, createdBy=88875409033, createdName=ms5000001342669861, createdTime=Fri Aug 28 15:37:53 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2021-04-07 湘雅科教

    受益匪浅!好文章。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1007270, encodeId=9eef100e270e4, content=赞 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIwY1mhUqD8P7iaes3oich3QTsdjk48gMrTIWJOIpDZObLeWWyEjhpBhxDsObwqWLGpMtPnMNxeQrbQ/132, createdBy=40802444180, createdName=云霄暖暖, createdTime=Thu Aug 12 13:54:23 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954489, encodeId=44ee954489c0, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:08:28 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905766, encodeId=62a6905e66f9, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/8c4455ab759843818e1f3ed7cde78e76/6d4732742c8a41a4950d5048ba13560e.jpg, createdBy=38792245245, createdName=Terry tao, createdTime=Mon Dec 07 18:08:18 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884790, encodeId=883e884e9037, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/3a02391511574e11a9aa4cf69c274058/49d417ece10545679c44d78fdbb7a881.jpg, createdBy=9b335137041, createdName=索和, createdTime=Sat Sep 12 18:20:12 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814741, encodeId=4f8d814e4173, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/09cdac1bb7b7426a8dd112bd3fd2ad8e/541a6884f1d446a584b766afce6b510b.jpg, createdBy=88875409033, createdName=ms5000001342669861, createdTime=Fri Aug 28 15:37:53 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2020-12-07 Terry tao

    谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1007270, encodeId=9eef100e270e4, content=赞 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIwY1mhUqD8P7iaes3oich3QTsdjk48gMrTIWJOIpDZObLeWWyEjhpBhxDsObwqWLGpMtPnMNxeQrbQ/132, createdBy=40802444180, createdName=云霄暖暖, createdTime=Thu Aug 12 13:54:23 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954489, encodeId=44ee954489c0, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:08:28 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905766, encodeId=62a6905e66f9, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/8c4455ab759843818e1f3ed7cde78e76/6d4732742c8a41a4950d5048ba13560e.jpg, createdBy=38792245245, createdName=Terry tao, createdTime=Mon Dec 07 18:08:18 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884790, encodeId=883e884e9037, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/3a02391511574e11a9aa4cf69c274058/49d417ece10545679c44d78fdbb7a881.jpg, createdBy=9b335137041, createdName=索和, createdTime=Sat Sep 12 18:20:12 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814741, encodeId=4f8d814e4173, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/09cdac1bb7b7426a8dd112bd3fd2ad8e/541a6884f1d446a584b766afce6b510b.jpg, createdBy=88875409033, createdName=ms5000001342669861, createdTime=Fri Aug 28 15:37:53 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2020-09-12 索和

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1007270, encodeId=9eef100e270e4, content=赞 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIwY1mhUqD8P7iaes3oich3QTsdjk48gMrTIWJOIpDZObLeWWyEjhpBhxDsObwqWLGpMtPnMNxeQrbQ/132, createdBy=40802444180, createdName=云霄暖暖, createdTime=Thu Aug 12 13:54:23 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954489, encodeId=44ee954489c0, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:08:28 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905766, encodeId=62a6905e66f9, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/8c4455ab759843818e1f3ed7cde78e76/6d4732742c8a41a4950d5048ba13560e.jpg, createdBy=38792245245, createdName=Terry tao, createdTime=Mon Dec 07 18:08:18 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884790, encodeId=883e884e9037, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/3a02391511574e11a9aa4cf69c274058/49d417ece10545679c44d78fdbb7a881.jpg, createdBy=9b335137041, createdName=索和, createdTime=Sat Sep 12 18:20:12 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814741, encodeId=4f8d814e4173, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/09cdac1bb7b7426a8dd112bd3fd2ad8e/541a6884f1d446a584b766afce6b510b.jpg, createdBy=88875409033, createdName=ms5000001342669861, createdTime=Fri Aug 28 15:37:53 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2020-08-28 ms5000001342669861

    谢谢

    0